Ticker LaunchRegulation A · Tier 2
Lee Pharmaceuticals, Inc.
Lee Pharmaceuticals, Inc. filed a Tier 2 Regulation A offering statement (Form 1-A) on Sep 13, 2022 for up to $50M at $0.01 per security. The SEC qualified the offering on Jan 17, 2023.
- Status
- Qualified
- Tier
- Tier 2
- Offering size
- $50M
- Offer price
- $0.01
- Security type
- Equity (common or preferred stock)
- Filed
- Sep 13, 2022
- Qualified
- Jan 17, 2023
- Industry
- Services-Computer Processing & Data Preparation
- State
- WY
More on this offering for subscribers
- Revenue, net income and total assets from the offering statement
- Employees
- Market cap at the offer price
- Amount raised, from the exit report (Form 1-Z)
- Auditor
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Offering statement (Form 1-A) Sep 13, 2022
- Exit report (Form 1-Z)
- All filings on EDGAR CIK 58411
Other qualified Technology Reg A offerings
- Fig Publishing, Inc.Feb 7, 2023 · $15M
- Datacentrex, Inc.Jan 9, 2023 · $4
- Dryworld Brands, Inc.Dec 27, 2022 · $10.8M
- Zerify, Inc.Dec 21, 2022 · $5M
- Careerlink Holdings, IncDec 12, 2022 · $50M
- Tekumo, Inc.Dec 9, 2022 · $10M